• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

硬化疗法治疗复发性淋巴管瘤。

Sclerotherapy in the treatment of recurrent lymphocele.

作者信息

Pope A J, Ormiston M C, Bogod D G

出版信息

Postgrad Med J. 1982 Sep;58(683):573-4. doi: 10.1136/pgmj.58.683.573.

DOI:10.1136/pgmj.58.683.573
PMID:7145799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2426465/
Abstract

The management of postoperative lymphoceles is often lengthy and unsatisfactory. We describe the successful treatment of a recurrent lymphocele by the repeated injection of sodium tetradecylsulphate (STD) after percutaneous aspiration. This method of treatment has not to our knowledge been previously described.

摘要

术后淋巴管瘤的处理通常耗时较长且效果不佳。我们描述了经皮抽吸后反复注射十四烷基硫酸钠（STD）成功治疗复发性淋巴管瘤的病例。据我们所知，这种治疗方法此前尚未见报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bed/2426465/740d70b5c37e/postmedj00213-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bed/2426465/e1f985f8d3bd/postmedj00213-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bed/2426465/740d70b5c37e/postmedj00213-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bed/2426465/e1f985f8d3bd/postmedj00213-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bed/2426465/740d70b5c37e/postmedj00213-0049-a.jpg

相似文献

1
Sclerotherapy in the treatment of recurrent lymphocele.硬化疗法治疗复发性淋巴管瘤。
Postgrad Med J. 1982 Sep;58(683):573-4. doi: 10.1136/pgmj.58.683.573.
2
[Sodium tetradecyl sulfate as a sclerosing solution in the therapy of esophageal varices].[十四烷基硫酸钠作为硬化剂溶液在食管静脉曲张治疗中的应用]
Nihon Rinsho. 1990 Apr;48(4):722-6.
3
Treatment of lymphangioma circumscriptum with sclerotherapy: an ignored effective remedy.硬化疗法治疗淋巴管瘤：一种被忽视的有效疗法。
J Cosmet Dermatol. 2011 Jun;10(2):156-8. doi: 10.1111/j.1473-2165.2011.00558.x.
4
Sclerotherapy of oral haemangioma with 3% sodium tetradecyl sulphate--a case report.用3%十四烷基硫酸钠硬化治疗口腔血管瘤——病例报告
Singapore Med J. 1986 Jun;27(3):244-6.
5
Multilocular hydrocele after sclerotherapy.硬化治疗后多房性鞘膜积液
Br J Urol. 1988 Jul;62(1):92-3. doi: 10.1111/j.1464-410x.1988.tb04280.x.
6
Sodium tetradecyl sulfate treatment of benign vascular anomalies.
J Oral Med. 1976 Jul-Sep;31(3):76-80.
7
Studies in sclerotherapy: I. Comparison of sodium tetradecyl sulphate (STS) with absolute alcohol (AA) as sclerosants in the treatment of esophageal varices.硬化疗法研究：I. 十四烷基硫酸钠（STS）与无水乙醇（AA）作为硬化剂治疗食管静脉曲张的比较。
J Clin Gastroenterol. 1990 Aug;12(4):378-80.
8
Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy.
Am Surg. 1988 Feb;54(2):81-4.
9
The treatment of facial haemangioma by percutaneous injections of sodium tetradecyl sulfate.经皮注射十四烷基硫酸钠治疗面部血管瘤
J Laryngol Otol. 1988 Jan;102(1):87-90. doi: 10.1017/s0022215100104074.
10
Sclerotherapy of varicose veins. Phlebographic demonstration of immediate venous spasm.
N Y State J Med. 1977 Feb;77(2):204-8.

引用本文的文献

1
A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection.1例经自体外周血注射治疗成功的主动脉旁淋巴管瘤病例。
Radiol Case Rep. 2017 Sep 28;12(4):760-763. doi: 10.1016/j.radcr.2017.08.014. eCollection 2017 Dec.
2
CASE REPORT Treatment of a Lower Extremity Lymphocele With Intraoperative Lymphatic Mapping.病例报告：术中淋巴管造影术治疗下肢淋巴囊肿
Eplasty. 2013 Nov 7;13:e57. eCollection 2013.
3
Pharmacology of sclerotherapy.硬化疗法的药理学

本文引用的文献

1
Lymphocyst: ultrasound diagnosis and urologic management.淋巴囊肿：超声诊断与泌尿外科处理
J Urol. 1975 Nov;114(5):740-5. doi: 10.1016/s0022-5347(17)67132-5.
2
Diagnosis and management of lymphoceles after renal transplantation.肾移植后淋巴囊肿的诊断与处理
Urology. 1977 Nov;10(5):497-502. doi: 10.1016/0090-4295(77)90148-0.
Semin Intervent Radiol. 2010 Dec;27(4):391-9. doi: 10.1055/s-0030-1267848.
4
Lymphocele.淋巴囊肿
Ann R Coll Surg Engl. 1993 Nov;75(6):387-92.